In Re Skelaxin (Metaxalone) Antitrust Litigation, MDL No. 2343 (E.D. Tenn.)
N/AOUTCOME:
Representation of a brand name pharmaceutical manufacturer in several federal and state class and individual actions alleging claims of monopolization and conspiracy to restrain generic competition, as ... well as RICO and state-law violations.
